A major conflict is unfolding at the US Food and Drug Administration. The dispute began with a private analysis of child deaths after COVID-19 vaccination and has now erupted into public view, raising questions about transparency.

A significant conflict is growing within the US Food and Drug Administration (FDA). The issue began with a private investigation by officials into 25 child deaths that occurred after COVID-19 vaccination. This sensitive analysis was not publicly shared. The disagreement then escalated when key details were leaked to the media, bringing the internal dispute to public attention. Now, the situation is fully in the open after the FDA's own vaccine chief released a memo on the matter. This rare public conflict has raised serious questions about the agency's transparency and its process for reviewing the safety of vaccines, revealing deep divisions among top health officials on a critical public health issue.

Original Author: Maryanne Demasi | Source: Brownstone Institute